Trials / Unknown
UnknownNCT03882749
Delivra-Celecoxib 8% Cream and Osteoarthritis
A Multicenter Observational Study on the Use of Delivra-Celecoxib 8% Cream on Pain Experienced by Patients With Osteoarthritis of the Knees
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (estimated)
- Sponsor
- Delivra, Inc. · Industry
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The observation of the clinical use of the Delivra Celecoxib cream (8%) in the treatment of osteoarthritis of the knee. Observations will be made over 12 weeks of treatment. Evaluations include: pain, functionality and patients global assessment of disease. Patients will self administer treatment as prescribed.
Conditions
Timeline
- Start date
- 2018-07-23
- Primary completion
- 2019-07-23
- Completion
- 2019-10-23
- First posted
- 2019-03-20
- Last updated
- 2019-03-20
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT03882749. Inclusion in this directory is not an endorsement.